Collegium Pharmaceutical, Inc. Profile Avatar - Palmy Investing

Collegium Pharmaceutical, Inc.

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta …

Drug Manufacturers - Specialty & Generic
US, Stoughton [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

  • Records
  • Forecasts [Soon]
Growth Rates
% YoY
% 3Yr
% 5Yr
% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
% - - Yield
0.00% Payout Ratio
Download
Cash Amount Pay Date
Download
Cash Amount Pay Date
End of COLL's Analysis
CIK: 1267565 CUSIP: 19459J104 ISIN: US19459J1043 LEI: - UEI: -
Secondary Listings
COLL has no secondary listings inside our databases.